CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-11 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −594 | $17.48 | $10K | 120,632 |
| 2022-07-01 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −1,394 | $18.16 | $25K | 323,453 |
| 2022-05-19 | Heffernan Michael Thomas Director | Grant or award | +14,035 | 28,023 | ||
| 2022-05-19 | Melincoff Gwen A Director | Grant or award | +14,035 | 34,983 | ||
| 2022-05-19 | SANTINI GINO Director | Grant or award | +14,035 | 58,171 | ||
| 2022-05-19 | McFarlane Neil F. Director | Grant or award | +14,035 | 31,880 | ||
| 2022-05-19 | Freund John Gordon Director | Grant or award | +14,035 | 34,983 | ||
| 2022-05-19 | Fallon John A. Director | Grant or award | +14,035 | 37,358 | ||
| 2022-05-19 | BOHLIN GAREN G Director | Grant or award | +14,035 | 34,983 | ||
| 2022-05-19 | Balice-Gordon Rita J. Director | Grant or award | +14,035 | 29,003 | ||
| 2022-04-06 | McFarlane Neil F. Director | Grant or award | +17,845 | 17,845 | ||
| 2022-03-16 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −734 | $18.99 | $14K | 148,384 |
| 2022-03-01 | Ciaffoni Joseph President and CEO | Sale | −65,083 | $18.37 | $1.2M | 335,858 |
| 2022-03-01 | Ciaffoni Joseph President and CEO | Sale | −11,011 | $19.04 | $210K | 324,847 |
| 2022-02-18 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −10,559 | $21.61 | $228K | 121,226 |
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +52,500 | 94,500 | ||
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +4,212 | 98,712 | ||
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −2,821 | $17.63 | $50K | 95,891 |
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −1,237 | $17.63 | $22K | 94,654 |
| 2022-02-10 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +36,750 | 130,308 |
Page 15 of 24 · 462 trades